SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Paul J. Fitzgerald, Is elevated norepinephrine an etiological factor in some cases of Parkinson’s disease?, Medical Hypotheses, 2014, 82, 4, 462

    CrossRef

  2. 2
    Laura Marsh, Depression and Parkinson’s Disease: Current Knowledge, Current Neurology and Neuroscience Reports, 2013, 13, 12

    CrossRef

  3. 3
    Jack J. Chen, Laura Marsh, Depression in Parkinson's Disease: Identification and Management, Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2013, 33, 9
  4. You have free access to this content4
    J. J. Ferreira, R. Katzenschlager, B. R. Bloem, U. Bonuccelli, D. Burn, G. Deuschl, E. Dietrichs, G. Fabbrini, A. Friedman, P. Kanovsky, V. Kostic, A. Nieuwboer, P. Odin, W. Poewe, O. Rascol, C. Sampaio, M. Schüpbach, E. Tolosa, C. Trenkwalder, A. Schapira, A. Berardelli, W. H. Oertel, Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease, European Journal of Neurology, 2013, 20, 1
  5. 5
    Jack J. Chen, Handbook of Parkinson’s Disease, 2013,

    CrossRef

  6. 6
    Jack Chen, Handbook of Parkinson's Disease, Fifth Edition, 2013,

    CrossRef

  7. 7
    M. Ujeyl, B. Müller-Oerlinghausen, Antidepressiva zur Behandlung der Depression bei Palliativpatienten, Der Schmerz, 2012, 26, 5, 523

    CrossRef

  8. 8
    David A. Gallagher, Anette Schrag, Psychosis, apathy, depression and anxiety in Parkinson's disease, Neurobiology of Disease, 2012, 46, 3, 581

    CrossRef

  9. 9
    Yoshiaki Kaji, Koichi Hirata, Apathy and Anhedonia in Parkinson's Disease, ISRN Neurology, 2011, 2011, 1

    CrossRef

  10. 10
    Dag Aarsland, Uwe Ehrt, Irena Rektorova, Cognitive and psychiatric disturbances in Parkinson’s disease, Aging Health, 2011, 7, 1, 123

    CrossRef

  11. 11
    Dag Aarsland, Sven Påhlhagen, Clive G. Ballard, Uwe Ehrt, Per Svenningsson, Depression in Parkinson disease—epidemiology, mechanisms and management, Nature Reviews Neurology, 2011, 8, 1, 35

    CrossRef

  12. 12
    Laili Soleimani, Kyle A.B. Lapidus, Dan V. Iosifescu, Diagnosis and Treatment of Major Depressive Disorder, Neurologic Clinics, 2011, 29, 1, 177

    CrossRef

  13. 13
    Shamim H. Nejad, Joshua L. Roffman, Karsten Kueppenbender, Felicia A. Smith, Jeff C. Huffman, Theodore A. Stern, Massachusetts General Hospital Handbook of General Hospital Psychiatry, 2010,

    CrossRef

  14. 14
    Eduardo Tolosa, Joan Santamaria, Carles Gaig, Yaroslau Compta, MOVEMENT DISORDERS 4, 2010,

    CrossRef

  15. 15
    Daniel Weintraub, MOVEMENT DISORDERS 4, 2010,

    CrossRef

  16. 16
    Marina Picillo, Mariangela Rocco, Paolo Barone, Dopamine receptor agonists and depression in Parkinson's disease, Parkinsonism & Related Disorders, 2009, 15, S81

    CrossRef

  17. 17
    Pasquale G. Frisina, Vahram Haroutunian, Leslie S. Libow, The neuropathological basis for depression in Parkinson's disease, Parkinsonism & Related Disorders, 2009, 15, 2, 144

    CrossRef

  18. 18
    Ludy Shih, Daniel Tarsy, Pharmacology and Therapeutics, 2009,

    CrossRef

  19. 19
    Murray A. Raskind, Diagnosis and Treatment of Depression Comorbid with Neurologic Disorders, The American Journal of Medicine, 2008, 121, 11, S28

    CrossRef

  20. 20
    J. Kulisevsky, J. Pagonabarraga, B. Pascual-Sedano, A. Gironell, C. García-Sánchez, M. Martínez-Corral, Motor changes during sertraline treatment in depressed patients with Parkinson’s disease, European Journal of Neurology, 2008, 15, 9
  21. You have free access to this content21
    Anette Schrag, Paolo Barone, Richard G. Brown, Albert F.G. Leentjens, William M. McDonald, Sergio Starkstein, Daniel Weintraub, Werner Poewe, Olivier Rascol, Cristina Sampaio, Glenn T. Stebbins, Christopher G. Goetz, Depression rating scales in Parkinson's disease: Critique and recommendations, Movement Disorders, 2007, 22, 8
  22. 22
    Joseph H. Friedman, Richard G. Brown, Cynthia Comella, Carol E. Garber, Lauren B. Krupp, Jau-Shin Lou, Laura Marsh, Lillian Nail, Lisa Shulman, C. Barr Taylor, Fatigue in Parkinson's disease: A review, Movement Disorders, 2007, 22, 3
  23. 23
    Teruhiko Higuchi, Mike Briley, Japanese experience with milnacipran, the first serotonin and norepinephrine reuptake inhibitor in Japan, Neuropsychiatric Disease and Treatment, 2007, 3, 1, 41

    CrossRef

  24. 24
    Leora L Borek, Kelvin L Chou, Joseph H Friedman, Management of the behavioral aspects of Parkinson’s disease, Expert Review of Neurotherapeutics, 2007, 7, 6, 711

    CrossRef

  25. 25
    Tjalf Ziemssen, Heinz Reichmann, Non-motor dysfunction in Parkinson's disease, Parkinsonism & Related Disorders, 2007, 13, 6, 323

    CrossRef

  26. 26
    Daniel Weintraub, Matthew B. Stern, Parkinson's Disease and Related Disorders, Part I, 2007,

    CrossRef

  27. 27
    Matthew A Menza, Roseanne D Dobkin, Humberto Marin, Cognitive and psychiatric aspects of Parkinson’s disease: treatment recommendations, Aging Health, 2006, 2, 1, 87

    CrossRef

  28. 28
    Nancy R. Barbas, Cognitive, Affective, and Psychiatric Features of Parkinson's Disease, Clinics in Geriatric Medicine, 2006, 22, 4, 773

    CrossRef

  29. 29
    F Tuna Burgut, Marina Benaur, Claire Henchcliffe, Late-life depression: a neuropsychiatric approach, Expert Review of Neurotherapeutics, 2006, 6, 1, 65

    CrossRef

  30. 30
    N. Chastan, A. Hartmann, Prise en charge médicale des patients atteints de syndromes parkinsoniens atypiques dégénératifs, Revue Neurologique, 2006, 162, 11, 1147

    CrossRef

  31. 31
    Luis Pintor, Eva Baillès, Francesc Valldeoriola, Eduard Tolosa, María J. Martí, Joan de Pablo, Response to 4-month treatment with reboxetine in Parkinson's disease patients with a major depressive episode, General Hospital Psychiatry, 2006, 28, 1, 59

    CrossRef

  32. 32
    M. Horstink, E. Tolosa, U. Bonuccelli, G. Deuschl, A. Friedman, P. Kanovsky, J. P. Larsen, A. Lees, W. Oertel, W. Poewe, O. Rascol, C. Sampaio, Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies (EFNS) and the Movement Disorder Society-European Section (MDS-ES). Part II: late (complicated) Parkinson's disease, European Journal of Neurology, 2006, 13, 11
  33. 33
    Spiridon Papapetropoulos, John Ellul, Andreas A. Argyriou, Elisabeth Chroni, Nicoletta P. Lekka, The effect of depression on motor function and disease severity of Parkinson's disease, Clinical Neurology and Neurosurgery, 2006, 108, 5, 465

    CrossRef

  34. 34
    Matthew Menza, Roseanne DeFronzo Dobkin, Humberto Marin, Treatment of depression in Parkinson’s disease, Current Psychiatry Reports, 2006, 8, 3, 234

    CrossRef

  35. 35
    Jim Lagopoulos, Gin S Malhi, Belinda Ivanovski, Catherine M Cahill, John GL Morris, A matter of motion or an emotional matter? Management of depression in Parkinson’s disease, Expert Review of Neurotherapeutics, 2005, 5, 6, 803

    CrossRef

  36. 36
    Daniel Weintraub, Knashawn H. Morales, Paul J. Moberg, Warren B. Bilker, Catherine Balderston, John E. Duda, Ira R. Katz, Matthew B. Stern, Antidepressant studies in Parkinson's disease: A review and meta-analysis, Movement Disorders, 2005, 20, 9
  37. 37
    F.J.E. Vajda, C. Solinas, Current approaches to management of depression in Parkinson’s Disease, Journal of Clinical Neuroscience, 2005, 12, 7, 739

    CrossRef

  38. 38
    Dwight L. Evans, Dennis S. Charney, Lydia Lewis, Robert N. Golden, Jack M. Gorman, K. Ranga Rama Krishnan, Charles B. Nemeroff, J. Douglas Bremner, Robert M. Carney, James C. Coyne, Mahlon R. Delong, Nancy Frasure-Smith, Alexander H. Glassman, Philip W. Gold, Igor Grant, Lisa Gwyther, Gail Ironson, Robert L. Johnson, Andres M. Kanner, Wayne J. Katon, Peter G. Kaufmann, Francis J. Keefe, Terence Ketter, Thomas P. Laughren, Jane Leserman, Constantine G. Lyketsos, William M. McDonald, Bruce S. McEwen, Andrew H. Miller, Dominique Musselman, Christopher O’Connor, John M. Petitto, Bruce G. Pollock, Robert G. Robinson, Steven P. Roose, Julia Rowland, Yvette Sheline, David S. Sheps, Gregory Simon, David Spiegel, Albert Stunkard, Trey Sunderland, Paul Tibbits, William J. Valvo, Mood Disorders in the Medically Ill: Scientific Review and Recommendations, Biological Psychiatry, 2005, 58, 3, 175

    CrossRef

  39. 39
    Daniel Weintraub, Matthew B. Stern, Psychiatric Complications in Parkinson Disease, The American Journal of Geriatric Psychiatry, 2005, 13, 10, 844

    CrossRef

  40. 40
    Hasmet A. Hanagasi, Murat Emre, Treatment of behavioural symptoms and dementia in Parkinson's disease, Fundamental & Clinical Pharmacology, 2005, 19, 2
  41. 41
    Daniel Weintraub, Paul Holtzheimer, William McDonald, Psychiatric Issues in Parkinson's Disease, 2005,

    CrossRef

  42. 42
    S. Papapetropoulos, J. Ellul, P. Polychronopoulos, E. Chroni, A registry-based, case–control investigation of Parkinson's disease with and without cognitive impairment, European Journal of Neurology, 2004, 11, 5
  43. 43
    Jack J. Chen, Anxiety, depression, and psychosis in Parkinson's disease: unmet needs and treatment challenges, Neurologic Clinics, 2004, 22, 3, S63

    CrossRef

  44. 44
    Edward C. Lauterbach, The neuropsychiatry of Parkinson's disease and related disorders, Psychiatric Clinics of North America, 2004, 27, 4, 801

    CrossRef

  45. 45
    Karen A. Sawabini, Ray L. Watts, Treatment of depression in Parkinson's disease, Parkinsonism & Related Disorders, 2004, 10, S37

    CrossRef

  46. 46
    I. Rektorová, I. Rektor, M. Bareš, V. Dostál, E. Ehler, Z. Fanfrdlová, J. Fiedler, H. Klajblová, P. Kulišt’ák, P. Ressner, J. Svátová, K. Urbánek, J. Velísková, Pramipexole and pergolide in the treatment of depression in Parkinson's disease: a national multicentre prospective randomized study, European Journal of Neurology, 2003, 10, 4
  47. 47
    William M McDonald, Irene H Richard, Mahlon R DeLong, Prevalence, etiology, and treatment of depression in Parkinson’s disease, Biological Psychiatry, 2003, 54, 3, 363

    CrossRef

  48. 48
    T.H. Chung, K.H.O. Deane, S. Ghazi-Noori, H. Rickards, C.E. Clarke, Systematic review of antidepressant therapies in Parkinson's disease☆, Parkinsonism & Related Disorders, 2003, 10, 2, 59

    CrossRef

  49. 49
    Andres M. Kanner, John J. Barry, The impact of mood disorders in neurological diseases: should neurologists be concerned?, Epilepsy & Behavior, 2003, 4, 3

    CrossRef

  50. 50
    K.Ranga R Krishnan, Biological risk factors in late life depression, Biological Psychiatry, 2002, 52, 3, 185

    CrossRef

  51. 51
    K.Ranga R Krishnan, Mahlon Delong, Helena Kraemer, Robert Carney, David Spiegel, Christopher Gordon, William McDonald, Mary Amanda Dew, George Alexopoulos, Kathleen Buckwalter, Perry D Cohen, Dwight Evans, Peter G Kaufmann, Jason Olin, Emeline Otey, Cynthia Wainscott, Comorbidity of depression with other medical diseases in the elderly, Biological Psychiatry, 2002, 52, 6, 559

    CrossRef

  52. 52
    Emmeline Edwards, Cheryl Kitt, Eugene Oliver, Judith Finkelstein, Molly Wagster, William M. McDonald, Depression and parkinson's disease: a new look at an old problem, Depression and Anxiety, 2002, 16, 1
  53. 53
    D. J. Burn, Depression in Parkinson's disease, European Journal of Neurology, 2002, 9,
  54. 54
    Theresa A. Zesiewicz, Robert A. Hauser, Depression in Parkinson’s disease, Current Psychiatry Reports, 2002, 4, 1, 69

    CrossRef

  55. 55
    Matthew A Menza, Psychiatric Aspects of Parkinson's Disease, Psychiatric Annals, 2002, 32, 2, 99

    CrossRef

  56. 56
    Olivier Rascol, Christopher Goetz, William Koller, Werner Poewe, Cristina Sampaio, Treatment interventions for Parkinson's disease: an evidence based assessment, The Lancet, 2002, 359, 9317, 1589

    CrossRef

  57. 57
    David J. Brooks, Miroslava Doder, Depression in Parkinsonʼs disease, Current Opinion in Neurology, 2001, 14, 4, 465

    CrossRef

  58. 58
    Irene H. Richard, Depression in Parkinson’s disease, Current Treatment Options in Neurology, 2000, 2, 3, 263

    CrossRef

  59. 59
    Theresa A. Zesiewicz, Robert A. Hauser, Depression in Patients with Parkinson??s Disease, CNS Drugs, 2000, 13, 4, 253

    CrossRef

  60. 60
    Joel E. Streim, David W. Oslin, Ira R. Katz, Buster D. Smith, Suzanne DiFilippo, Thomas B. Cooper, Thomas Ten Have, Drug Treatment of Depression in Frail Elderly Nursing Home Residents, The American Journal of Geriatric Psychiatry, 2000, 8, 2, 150

    CrossRef

  61. 61
    Laura Marsh, Neuropsychiatric Aspects of Parkinson’s Disease, Psychosomatics, 2000, 41, 1, 15

    CrossRef

  62. 62
    Alessandro Di Rocco, John D. Rogers, Richard Brown, Peter Werner, Teodoro Bottiglieri, S-adenosyl-methionine improves depression in patients with Parkinson's disease in an open-label clinical trial, Movement Disorders, 2000, 15, 6
  63. 63
    Paul J Goodnick, Mark Hernandez, Treatment of depression in comorbid medical illness, Expert Opinion on Pharmacotherapy, 2000, 1, 7, 1367

    CrossRef

  64. 64
    Theresa A. Zesiewicz, Michael Gold, Ganesh Chari, Robert A. Hauser, Current Issues in Depression in Parkinson's Disease, The American Journal of Geriatric Psychiatry, 1999, 7, 2, 110

    CrossRef

  65. 65
    Jeffrey L. Cummings, Donna L. Masterman, Depression in patients with Parkinson's disease, International Journal of Geriatric Psychiatry, 1999, 14, 9
  66. 66
    Irene Hegeman Richard, Angeline Maughn, Roger Kurlan, Do serotonin reuptake inhibitor antidepressants worsen Parkinson's disease? A retrospective case series, Movement Disorders, 1999, 14, 1
  67. 67
    Dag Aarsland, Karen Karlsen, Neuropsychiatric aspects of parkinson’s disease, Current Psychiatry Reports, 1999, 1, 1, 61

    CrossRef

  68. 68
    Jeffrey L. Cummings, Principles of neuropsychiatry: Towards a neuropsychiatric epistemology, Neurocase, 1999, 5, 3, 181

    CrossRef

  69. 69
    Matthew A. Menza, Benjamin L. Liberatore, PSYCHIATRY IN THE GERIATRIC NEUROLOGY PRACTICE, Neurologic Clinics, 1998, 16, 3, 611

    CrossRef

  70. 70
    Keizo Yoshida, Hisashi Higuchi, Mitsuhiro Kamata, Masaki Yoshimoto, Tetsuo Shimizu, Yasuo Hishikawa, Single and repeated electroconvulsive shocks activate dopaminergic and 5-hydroxytryptaminergic neurotransmission in the frontal cortex of rats, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 1998, 22, 2, 435

    CrossRef

  71. 71
    Robert A. Hauser, Theresa A. Zesiewicz, Sertraline for the treatment of depression in parkinson's disease, Movement Disorders, 1997, 12, 5
  72. 72
    S. Giménez-Roldán, J.L. Dobato, D. Mateo, Treatment of depression in Parkinson's disease with moclobemide: A pilot open-label study, Parkinsonism & Related Disorders, 1997, 3, 4, 219

    CrossRef

  73. 73
    Jolyon Meara, Serotonin and the extrapyramidal system — a neurological perspective, Human Psychopharmacology: Clinical and Experimental, 1996, 11, S2
  74. 74
    Kathleen Franco-Bronson, THE MANAGEMENT OF TREATMENT-RESISTANT DEPRESSION IN THE MEDICALLY ILL, Psychiatric Clinics of North America, 1996, 19, 2, 329

    CrossRef

  75. 75
    George S. Alexopoulos, Methodology of Treatment Studies in Geriatric Depression, The American Journal of Geriatric Psychiatry, 1995, 3, 4, 280

    CrossRef

  76. 76
    Frits J. Huyse, Wilhelm A. Zwaan, Ralph Kupka, The applicability of antidepressants in the depressed medically ill: an open clinical trial with fluoxetine, Journal of Psychosomatic Research, 1994, 38, 7, 695

    CrossRef

  77. 77
    Nicolas Hasle, Psychiatric side effects of levodopa treatment of parkinsonism A survey, Nordic Journal of Psychiatry, 1993, 47, 5, 379

    CrossRef

  78. 78
    Shitij Kapur, J. John Mann, Role of the dopaminergic system in depression, Biological Psychiatry, 1992, 32, 1, 1

    CrossRef

  79. 79
    H. A. Ring, M. R. Trimble, Affective disturbance in parkinson's disease, International Journal of Geriatric Psychiatry, 1991, 6, 6
  80. 80
    Matthew A. Menza, Jacob Sage, Eric Marshall, Ronald Cody, Roger Duvoisin, Mood changes and “on-off” phenomena in Parkinson's disease, Movement Disorders, 1990, 5, 2
  81. 81
    Donald L. Friedenberg, Jeffrey L. Cummings, Parkinson's Disease, Depression, and the On-Off Phenomenon, Psychosomatics, 1989, 30, 1, 94

    CrossRef

  82. 82
    Lon S. Schneider, Helena C. Chui, James A. Severson, R. Bruce Sloane, decreased platelet 3H-imipramine binding in parkinson's disease, Biological Psychiatry, 1988, 24, 3, 348

    CrossRef

  83. 83
    Daniel Rogers, Bradyphrenia in parkinsonism: a historical review, Psychological Medicine, 1986, 16, 02, 257

    CrossRef

  84. 84
    Norman S. Harvey, Psychiatric disorders in parkinsonism: 1. Functional illnesses and personality, Psychosomatics, 1986, 27, 2, 91

    CrossRef

  85. 85
    Jacques Barber, Rachel Tomer, Hava Sroka, Michael S. Myslobodsky, Does unilateral dopamine deficit contribute to depression?, Psychiatry Research, 1985, 15, 1, 17

    CrossRef

  86. 86
    Randolph B. Schiffer, Robert M. Herndon, Richard A. Rudick, Treatment of Pathologic Laughing and Weeping with Amitriptyline, New England Journal of Medicine, 1985, 312, 23, 1480

    CrossRef

  87. 87
    R. Cantello, A. Riccio, L. Scarzella, D. Leotta, B. Bergamasco, Depression in Parkinson disease: a disabling but neglected factor, The Italian Journal of Neurological Sciences, 1984, 5, 4, 417

    CrossRef

  88. 88
    R. Jouvent, P. Abensour, A.M. Bonnet, D. Widlocher, Y. Agid, F. Lhermitte, Antiparkinsonian and antidepressant effects of high doses of bromocriptine, Journal of Affective Disorders, 1983, 5, 2, 141

    CrossRef

  89. 89
    Paul A.M. van Dongen, The human locus coeruleus in neurology and psychiatry, Progress in Neurobiology, 1981, 17, 1-2, 97

    CrossRef

  90. 90
    Richard Mayeux, Movement Disorders, 1981,

    CrossRef

  91. 91
    W. H. Oertel, A. Berardelli, B. R. Bloem, U. Bonuccelli, D. Burn, G. Deuschl, E. Dietrichs, G. Fabbrini, J. J. Ferreira, A. Friedman, P. Kanovsky, V. Kostic, A. Nieuwboer, P. Odin, W. Poewe, O. Rascol, C. Sampaio, M. Schüpbach, E. Tolosa, C. Trenkwalder, Late (Complicated) Parkinson's Disease,
  92. 92
    Shabnam Ghazi-Noori, Tin Hei Chung, Katherine Deane, Hugh E Rickards, Carl E Clarke, Therapies for depression in Parkinson's disease, The Cochrane Library,